Pfizer, Inc. (PFE) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Pfizer, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.058 Good day, everyone, and welcome to Pfizer's first quarter 2026 earnings conference 00:00:05.058 -- 00:00:08.722 call. Today's call is being recorded. 00:00:08.722 -- 00:00:13.008 At this time, I would like to turn the call over to Francesca DiMartino, Chief Investor 00:00:13.008 -- 00:00:16.132 Relations Officer and Senior Vice President. 00:00:16.132 -- 00:00:18.655 Please go ahead, ma'am. 00:00:18.655 -- 00:00:21.499 Good morning, and welcome to Pfizer's earnings call. 00:00:21.499 -- 00:00:24.989 I'm Francesca DiMartino, Chief Investor Relations Officer. 00:00:24.989 -- 00:00:27.952 On behalf of the Pfizer team, thank you for joining us. 00:00:27.952 -- 00:00:32.737 This call is being made available via audio webcast at Pfizer.com. 00:00:32.737 -- 00:00:37.621 Earlier this morning, we released our results for the first quarter 2026 via press release 00:00:37.621 -- 00:00:41.225 that is available on our website at Pfizer.com. 00:00:41.225 -- 00:00:47.070 I'm joined today by Dr. Albert Bourla, our chairman and CEO, and Dave Denton, our CFO. 00:00:47.070 -- 00:00:51.835 Albert and Dave have some prepared remarks, and we will then open the call for questions. 00:00:51.835 -- 00:00:55.516 Members of our leadership team will be available for the Q&A session. 00:00:55.516 -- 00:00:59.380 Before we get started, I want to remind you that we will be making forward-looking statements 00:00:59.380 -- 00:01:02.704 and discussing certain non-GAAP financial measures. 00:01:02.704 -- 00:01:06.929 I encourage you to read the disclaimers in our slide presentation, the press release 00:01:06.929 -- 00:01:11.614 we issued this morning, and the disclosures in our SEC filings, which are all available 00:01:11.614 -- 00:01:14.618 on the IR website on ...